Literature DB >> 32580976

Patient-level and system-level barriers associated with treatment delays for ST elevation myocardial infarction in China.

Xuejun Yin1, Yibo He2, Jing Zhang3, Feier Song4, Jin Liu2, Guoli Sun2, Yan Liang5, Jianfeng Ye6, Yunzhao Hu7, Mingcai Song8, Cong Chen5, Qingbo Xu5, Ning Tan2, Jiyan Chen2, Yong Liu9, Hueiming Liu1, Maoyi Tian1,10.   

Abstract

OBJECTIVE: This study aims to understand the current ST elevated myocardial infarction (STEMI) treatment process in Guangdong Province and explore patient-level and system-level barriers associated with delay in STEMI treatment, so as to provide recommendations for improvement.
METHODS: This is a qualitative study. Data were collected using semistructured, face-to-face individual interviews from April 2018 to January 2019. Participants included patients with STEMI, cardiologists and nurses from hospitals, emergency department doctors, primary healthcare providers, local health governors, and coordinators at the emergency medical system (EMS). An inductive thematic analysis was adopted to generate overarching themes and subthemes for potential causes of STEMI treatment delay. The WHO framework for people-centred integrated health services was used to frame recommendations for improving the health system.
RESULTS: Thirty-two participants were interviewed. Patient-level barriers included poor knowledge in recognising STEMI symptoms and not calling EMS when symptoms occurred. Limited capacity of health professionals in hospitals below the tertiary level and lack of coordination between hospitals of different levels were identified as the main system-level barriers. Five recommendations were provided: (1) enhance public health education; (2) strengthen primary healthcare workforce; (3) increase EMS capacity; (4) establish an integrated care model; and (5) harness government's responsibilities.
CONCLUSIONS: Barriers associated with delay in STEMI treatment were identified at both patient and system levels. The results of this study provide a useful evidence base for future intervention development to improve the quality of STEMI treatment and patient outcomes in China and other countries in a similar situation. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute myocardial infarction; health care delivery

Mesh:

Year:  2020        PMID: 32580976     DOI: 10.1136/heartjnl-2020-316621

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

1.  Pre-hospital delay in patients with acute myocardial infarction in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project.

Authors:  Dan-Qing Hu; Yong-Chen Hao; Jun Liu; Na Yang; Yi-Qian Yang; Zhao-Qing Sun; Dong Zhao; Jing Liu
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.189

2.  The impact of chest pain center on treatment delay of STEMI patients: a time series study.

Authors:  Xiaolin Sun; Bo Yao; Kexin Shi; Yajiong Xue; Huigang Liang
Journal:  BMC Emerg Med       Date:  2021-11-06

3.  Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study.

Authors:  You Zhang; Shan Wang; Qianqian Cheng; Junhui Zhang; Datun Qi; Xianpei Wang; Zhongyu Zhu; Muwei Li; Dayi Hu; Chuanyu Gao
Journal:  BMJ Open       Date:  2021-12-20       Impact factor: 2.692

4.  Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy.

Authors:  Kaiyin Li; Bin Zhang; Bo Zheng; Yan Zhang; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.